Shareholder information
Collapse navigation.
Find details below about Haleon plc's share buybacks.
On 29 February 2024, Haleon plc announced a capital allocation of £500 million for share buybacks during 2024.
We returned £500m to shareholders through off-market buybacks of shares from Pfizer Inc. of £315m and £115m in March and October 2024, respectively, with the remaining £70m completed through an on-market buyback programme which commenced on 1 August 2024 and ceased on 1 October 2024.
A breakdown of the daily transaction details of the on-market buyback programme is available here.